Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Rhabdomyosarcoma 1Desmoplastic Small Round Cell Tumor 1

Interventions

Cyclophosphamide 2seclidemstat 1prexasertib 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1Zoledronic Acid 1Vinorelbine 1Vincristine 1Topotecan 1Temozolomide 1Ramucirumab 1PM 01183 1Irinotecan 1HhAntag691 1Granulocyte Colony-Stimulating Factor 1Filgrastim 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Desmoplastic Small Round Cell Tumor × prexasertib × Clear all
NCT04095221 2025-02-20

A Study of the Drugs Prexasertib, Irinotecan, and Temozolomide in People With Desmoplastic Small Round Cell Tumor and Rhabdomyosarcoma

Memorial Sloan Kettering Cancer Center

Phase 1/2 Completed
21 enrolled
Sarcoma

Rhabdomyosarcoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡